Professionals say getting these body weight-loss prescription drugs by means of alternate routes can be dangerous, considering that neither Novo nor Eli Lilly promote their medications to other manufacturers.In a statement, Novo mentioned it doesn't supply or market bulk semaglutide, and that different compounded products and solutions "do not have